FDA Greenlights Gene Therapy, Because Patience Isnāt a Drug
In a plot twist worthy of a soap opera, the FDA announced itās 'clearing the way' for Sarepta Therapeutics to resume shipments of their gene therapy for Duchenne muscular dystrophy to some patients. Yes, just some, because apparently miracles come with fine print. The FDAās official line? Theyāre 'clearing the way,' which sounds a bit like popping open a space in traffic, except this lane could save lives. Gene therapy shipments resumed, but if you were hoping for a full-on party, well, itās more of a dignified nod: progress served with a side of bureaucratic seasoning.
Share the Story
FDA finally said 'go' for gene therapy shipments, or as they put it, 'clearing the way.' Someone tell my delivery app to work on that kind of speed. #MiracleMiles
Oh look, FDA is 'clearing the way' for some shipments like it's GPS rerouting around traffic jams. Your gene therapy might arrive sometime between now and the heat death of the universe.
Resuming gene therapy shipments to some patients is like giving only half your friends passes to the Electric Daisy Carnivalāexclusive, selective, and sure to cause FOMO.
Source: Statnews | Published: 7/28/2025 | Author: Adam Feuerstein
More Articles in Health
Sam Altmanās Hospital Stay: AI Genius Vs. Semaglutide Junk Food
TrumpRX: Medicareās New Weight Loss CokeāNow in Pill Form!
90-Year-Old Powerlifters Crush Age, Bones, and Expectations
Forty-Something Brits Take on Identical Triplets: Sleep, Who Needs It?
Pickleball Achilles: From Court Pop to Star-Powered Sobfest
